Ashton, Nicholas J.
Janelidze, Shorena http://orcid.org/0000-0003-2869-8378
Mattsson-Carlgren, Niklas
Binette, Alexa Pichet http://orcid.org/0000-0001-5218-3337
Strandberg, Olof
Brum, Wagner S.
Karikari, Thomas K. http://orcid.org/0000-0003-1422-4358
González-Ortiz, Fernándo
Di Molfetta, Guglielmo
Meda, Francisco J. http://orcid.org/0000-0002-3343-7351
Jonaitis, Erin M.
Koscik, Rebecca Langhough http://orcid.org/0000-0003-0025-744X
Cody, Karly http://orcid.org/0000-0001-5996-2560
Betthauser, Tobey J. http://orcid.org/0000-0001-8856-1352
Li, Yan
Vanmechelen, Eugeen http://orcid.org/0000-0002-9466-5366
Palmqvist, Sebastian http://orcid.org/0000-0002-9267-1930
Stomrud, Erik
Bateman, Randall J. http://orcid.org/0000-0002-7729-1702
Zetterberg, Henrik http://orcid.org/0000-0003-3930-4354
Johnson, Sterling C. http://orcid.org/0000-0002-8501-545X
Blennow, Kaj http://orcid.org/0000-0002-1890-4193
Hansson, Oskar http://orcid.org/0000-0001-8467-7286
Article History
Received: 24 April 2022
Accepted: 3 October 2022
First Online: 1 December 2022
Competing interests
: N.J.A. has given lectures in symposia sponsored by Eli Lilly. S.J. has no disclosures. N.M.-C. has no disclosures. A.P.B. has no disclosures. O.S. has no disclosures. W.S.B. has no disclosures. T.K.K. has no disclosures. F.G.-O. has no disclosures. G.D.M. has no disclosures. F.J.M. has no disclosures. E.M.J. has no disclosures. R.L.K. has no disclosures. K.C. has no disclosures. T.J.B. has no disclosures. Y.L. has no disclosures. E.V. is a cofounder of ADx Neurosciences. S.P. has served on scientific advisory boards and/or given lectures in symposia sponsored by Biogen, Eli Lilly, Geras Solutions and Roche. E.S. has no disclosures. R.J.B. has equity ownership interest in C2N Diagnostics and may receive income based on technology licensed or optioned by Washington University to C2N Diagnostics, receives income from C2N Diagnostics for serving on the scientific advisory board and has received honoraria as a speaker/consultant/advisory board member from Amgen, Eisai and Roche. H.Z. has served at scientific advisory boards and/or as a consultant for Abbvie, Alector, Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies, CogRx and Red Abbey Labs, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen, and is a cofounder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). S.C.J. has within the past 3 years served at scientific advisory boards and/or as a consultant for Roche Diagnostics, Prothena and Eisai and has received research support from Cerveau Technologies. K.B. has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, BioArctic, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Ono Pharma, Pharmatrophix, Prothena, Roche Diagnostics and Siemens Healthineers, and is a cofounder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. O.H. has acquired research support (for the institution) from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer and Roche. In the past 2 years, he has received consultancy/speaker fees from Amylyx, Alzpath, BioArctic, Biogen, Cerveau, Fujirebio, Genentech, Novartis, Roche and Siemens.